Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: MisterElbows	10/8/2004 3:20:32 PM
	Read Replies (1) of 14101

Had a discussion with a US lawyer friend who works in civil litigation and property damage cases (he actually worked with Celino & Barnes years ago!). He is certain Pfizer will have to pull Celebrex due to the massive liability they will face if even one person can prove with reasonable certainty that Celebrex caused a cardiac event. It is not just the civil suits that could be a massive problem for Celebrex, but if it could be proven that Pfizer acted negligently by not removing the drug in the face of evidence linking it with cardiac problems, then the CEO and BOD could be held criminally responsible. The risks are just far to high for Pfizer to play in this game too much longer. I then pointed out to him that it's not just about civil and criminal activity (which is bad enough), but Pfizers brand name would be badly sullied for a long long time. In light of this, is it no doubt that J&J now wants to talk deal again with Dimethaid?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next